Smith+Nephew buyback

2026-11-03

Smith+Nephew cuts outlook, confirms failed merger talks with J&J's orthopaedics unit

Smith+Nephew confirmed failed merger talks with Johnson & Johnson's orthopaedics unit due to leadership disagreements. Consequently, the company cut its full-year revenue and profit forecasts citing p

reuters · 2026-11-03 23:34 UTC

2026-08-03

Smith+Nephew Cuts Annual Revenue Expectations Amid US Orthopaedic Unit Weakness

Smith+Nephew reduced its full-year revenue growth forecast to approximately 4% due to persistent weakness in US knee and hip implant demand. The company expects new product launches to cushion the imp

reuters · 2026-08-03 23:13 UTC

2026-05-05

Smith+Nephew Keeps Outlook, Plans $500M Buyback as Revenue Rises

Smith+Nephew reported a 3.1% rise in underlying Q1 revenue to $1.5 billion, maintaining its annual outlook while announcing a $500 million share buyback amidst supply chain challenges.

reuters · 2026-05-05 23:21 UTC

Media coverage (3)

Smith+Nephew cuts outlook, confirms failed merger talks with J&J's orthopaedics unitreuters
Smith+Nephew Cuts Annual Revenue Expectations Amid US Orthopaedic Unit Weaknessreuters
Smith+Nephew Keeps Outlook, Plans $500M Buyback as Revenue Risesreuters

Smith+Nephew buyback

Smith+Nephew cuts outlook, confirms failed merger talks with J&J's orthopaedics unit

Smith+Nephew Cuts Annual Revenue Expectations Amid US Orthopaedic Unit Weakness

Smith+Nephew Keeps Outlook, Plans $500M Buyback as Revenue Rises

Media coverage (3)

Related topics